Bionic Pancreas in CFRD
NCT: NCT06449677 · RECRUITING
Brief Summary
This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.
Frequently Asked Questions
What is Bionic Pancreas in CFRD?
Bionic Pancreas in CFRD is a clinical trial registered under NCT06449677. Current status: RECRUITING.
What is the status of NCT06449677?
The current status of NCT06449677 (Bionic Pancreas in CFRD) is: RECRUITING.
When did Bionic Pancreas in CFRD start?
Bionic Pancreas in CFRD started on 2024-09-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.